SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-20-018054
Filing Date
2020-09-21
Accepted
2020-09-21 09:00:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 178511
  Complete submission text file 0001493152-20-018054.txt   180136
Mailing Address C/O GLOBIS CAPITAL PARTNERS LP 60 BROAD ST NEW YORK NY 10004
Business Address (000)000 0000
PACKER PAUL (Filed by) CIK: 0001268460 (see all company filings)

Type: SC 13G

Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Subject) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-84090 | Film No.: 201185289
SIC: 2834 Pharmaceutical Preparations